ÂÜÀòÂÒÂ×

Jack Shi is the current Vice President of Clinical Pharmacology at Arrowhead Pharmaceuticals. Prior to this, they served as Executive Director at Ultragenyx Pharmaceutical Inc. from August 2016 to March 2020. Jack has also held the position of Director at Incyte from March 2003 to August 2016, and Sr. Investigator II at Bristol-Myers Squibb from January 2001 to December 2002. Jack began their career as a Sr. Research Scientist at DuPont Pharmaceuticals in January 1997 and held that position until December 2001.

Jack Shi earned their Doctor of Philosophy (Ph.D.) from Purdue University and their B.S. from Fudan University.

Jack Shi reports to Javier San Martin, CMO. Some of their coworkers include Erik Bush - GVP, Biology, Fred Fleitz - GVP, Chemistry, Manufacturing & Controls, and Peter Carignan - VP, Clinical Operations.